ArticleFrontiers in immunology2026

Reversing chemoresistance in ovarian cancer: network pharmacology reveals how hydroxychloroquine/sulfasalazine duotherapy remodels tumor inflammatory-immune microenvironment.

Xin Hong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.